Lupin receives approval from USFDA for Tenofovir Alafenamide tablets

Lupin receives approval from USFDA for Tenofovir Alafenamide tablets

This product will be manufactured at Lupin’s Nagpur facility in India

FPJ Web DeskUpdated: Friday, March 31, 2023, 01:07 PM IST
article-image
Lupin receives approval from USFDA for Tenofovir Alafenamide tablets | Image: Lupin (Representative)

Lupin Limited today announced that it has received approval from the United States Food and Drug Administration (U.S.FDA) for its abbreviated New Drug Application for Tenofovir Alafenamide tablets, 25 mg, via an exchange filing.

It is the generic equivalent of Vemlidy Tablets, 25 mg, of Gilead Sciences, Inc.

This product will be manufactured at Lupin’s Nagpur facility in India.

RECENT STORIES

India’s Festive Season To Create Over 2.16 Lakh Jobs In H2 2025, Driven B Retail, E-commerce And...

India’s Festive Season To Create Over 2.16 Lakh Jobs In H2 2025, Driven B Retail, E-commerce And...

Gold Drops ₹500 Amid Stockist Selling, Silver Falls ₹1,000 Despite Global Gains

Gold Drops ₹500 Amid Stockist Selling, Silver Falls ₹1,000 Despite Global Gains

Tech Mahindra Q1 FY26 Net Profit Rises 33.9% To ₹1,140.6 Crore; Revenue Grows Marginally To...

Tech Mahindra Q1 FY26 Net Profit Rises 33.9% To ₹1,140.6 Crore; Revenue Grows Marginally To...

Govt Approves ₹20,000 Crore Investment Power For NTPC To Add 60 GW Green Energy By 2032

Govt Approves ₹20,000 Crore Investment Power For NTPC To Add 60 GW Green Energy By 2032

Telecom Operator MTNL Defaults On ₹8,585 Crore Loans to 7 PSU Banks

Telecom Operator MTNL Defaults On ₹8,585 Crore Loans to 7 PSU Banks